Researchers with the FDA’s Office of Prescription Drug Promotion (OPDP) will move forward with two proposed studies on the disclosure of FDA accelerated approval information on direct-to-consumer (DTC) websites. The studies will replicate and extend prior OPDP research.  A comment generated from OPDP’s announcement of the research in June 2021, contended the proposed research... Read More